AU2001265182A1 - Inhibitors of matrix metalloproteinases - Google Patents

Inhibitors of matrix metalloproteinases

Info

Publication number
AU2001265182A1
AU2001265182A1 AU2001265182A AU6518201A AU2001265182A1 AU 2001265182 A1 AU2001265182 A1 AU 2001265182A1 AU 2001265182 A AU2001265182 A AU 2001265182A AU 6518201 A AU6518201 A AU 6518201A AU 2001265182 A1 AU2001265182 A1 AU 2001265182A1
Authority
AU
Australia
Prior art keywords
inhibitors
matrix metalloproteinases
metalloproteinases
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265182A
Inventor
Rafael Fridman
Shahriar Mobashery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Publication of AU2001265182A1 publication Critical patent/AU2001265182A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/02—Three-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
AU2001265182A 2000-05-30 2001-05-30 Inhibitors of matrix metalloproteinases Abandoned AU2001265182A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20787400P 2000-05-30 2000-05-30
US60207874 2000-05-30
US22685800P 2000-08-22 2000-08-22
US60226858 2000-08-22
PCT/US2001/017448 WO2001092244A1 (en) 2000-05-30 2001-05-30 Inhibitors of matrix metalloproteinases

Publications (1)

Publication Number Publication Date
AU2001265182A1 true AU2001265182A1 (en) 2001-12-11

Family

ID=26902682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265182A Abandoned AU2001265182A1 (en) 2000-05-30 2001-05-30 Inhibitors of matrix metalloproteinases

Country Status (5)

Country Link
US (2) US6703415B2 (en)
EP (1) EP1309579B1 (en)
AU (1) AU2001265182A1 (en)
DE (1) DE60114022T2 (en)
WO (1) WO2001092244A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040105897A1 (en) * 2001-11-29 2004-06-03 Greystone Medical Group, Inc. Composition and method for the therapeutic modulation of matrix metalloproteinase
WO2003084540A2 (en) * 2002-04-09 2003-10-16 Novartis Ag Compositions comprising mmp7 modulators for the treatment of chronic pain
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
US8231858B2 (en) 2003-02-10 2012-07-31 Ge Healthcare Limited Diagnostic imaging agents with MMP inhibitory activity
EP1613269B1 (en) 2003-04-04 2015-02-25 Incyte Corporation Compositions, methods and kits relating to her-2 cleavage
WO2004113502A2 (en) * 2003-06-20 2004-12-29 Avalon Pharmaceuticals, Inc. Identification of therapeutic agents using genetic fingerprinting
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
WO2006036928A2 (en) * 2004-09-27 2006-04-06 Wayne State University Inhibitors of matrix metalloproteinases to treat neurological disorders
WO2006125208A1 (en) * 2005-05-19 2006-11-23 Wayne State University Inhibitors of matrix metalloproteinases
JP2012518001A (en) * 2009-02-13 2012-08-09 インディアナ ユニバーシティ リサーチ アンド テクノロジー コーポレイション Compounds and methods for inhibiting MMP2 and MMP9
CN101559076B (en) * 2009-05-27 2012-08-29 西北大学 Anti-tumor-stroma metalloprotease inhibitor
US8937151B2 (en) 2010-03-04 2015-01-20 University Of Notre Dame Du Lac Gelatinase inhibitors and prodrugs
CN106536500B (en) 2014-02-20 2020-01-10 圣母大学 Selective matrix metalloproteinase inhibitors
US10357546B2 (en) * 2014-09-19 2019-07-23 University Of Notre Dame Du Lac Acceleration of diabetic wound healing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949474A (en) * 1956-02-06 1960-08-16 Rohm & Haas New unsaturated glycidyl ethers, polymers thereof and methods for producing them
US2965651A (en) * 1957-09-20 1960-12-20 Monsanto Chemicals Episulfide compounds
US3222326A (en) * 1962-01-29 1965-12-07 Du Pont Polymers of alkylene thioethers
US4797218A (en) * 1985-09-09 1989-01-10 Ciba-Geigy Corporation Stabilizer thiirane derivatives containing hindered phenol groups
US5288722A (en) * 1989-03-06 1994-02-22 Takeda Chemical Industries, Ltd. 6-amino-6-desoxyfumagillols, production and use thereof
DE69511089T2 (en) * 1994-06-22 1999-12-16 British Biotech Pharm METALLOPROTEINASE INHIBITORS
US5739313A (en) * 1995-11-13 1998-04-14 Regents Of The University Of Minnesota Radionuclide labeling of vitamin B12 and coenzymes thereof
FR2757165B1 (en) * 1996-12-12 1999-02-19 Inst Francais Du Petrole ESTER OF MALEIMIDOBENZOIC ACID
GB9702088D0 (en) * 1997-01-31 1997-03-19 Pharmacia & Upjohn Spa Matrix metalloproteinase inhibitors

Also Published As

Publication number Publication date
US20040127478A1 (en) 2004-07-01
US20020037916A1 (en) 2002-03-28
US7144917B2 (en) 2006-12-05
DE60114022D1 (en) 2006-02-23
EP1309579B1 (en) 2005-10-12
EP1309579A1 (en) 2003-05-14
WO2001092244A1 (en) 2001-12-06
DE60114022T2 (en) 2006-07-13
US6703415B2 (en) 2004-03-09

Similar Documents

Publication Publication Date Title
AU2002228302A1 (en) Matrix metalloproteinase inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU2001244399A1 (en) Gamma-secretase inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2001294557A1 (en) Thrombin inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001274894A1 (en) Novel matrix metalloproteinases
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2001241498A1 (en) Matrix metalloproteinase inhibitors and uses thereof
AU2001274344A1 (en) Tissue inhibitors of matrix metalloproteinases
AU1588901A (en) Protease inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU1474801A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors
AU2002316552A1 (en) Inhibitor of t cell activation
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU8005100A (en) Inhibitors of neuraminidases